Table 1.
Gene | Viability | Knockout phenotype | Ref. |
---|---|---|---|
Lyn | Viable | ↓ B cell numbers, ↓ surface IgM levels, ↑ BCR responses, ↑ serum IgM levels, slightly ↓ T-dependent and T-independent responses, ↑ B-1 cells, autoantibodies with age | 24, 28–32 |
Fyn | Viable | Normal B cell numbers, normal BCR responses, ↓ IL-5 response | 33, 34 |
p85α | Perinatal lethality | Like xid with more severe block at proB to preB stage | 35, 36 |
CD19 | Viable | ↓ B cell numbers, ↓ BCR responses, ↓ serum Ig levels, ↓ T-dependent responses, normal or ↑ T-independent responses, ↓ B-1 cells | 37–39 |
Gαq | Viable | No B cell phenotype described | 40 |
Gα11 | Viable | No B cell phenotype described | 41 |
SHIP | Viable | ↓ B cell numbers, ↓ surface IgM levels, ↑ BCR responses, ↓ FcγRIIb-mediated inhibition of BCR, ↑ serum Ig levels, normal T-dependent responses, ↑ T-independent responses | 42–44 |
PTEN | Embryonic lethal | In +/− mice: ↑ number of activated B cells (polyclonal expansion), ↑ autoantibodies | 45–49 |
CD22 | Viable | ↓ B cell numbers, ↓ surface IgM levels, ↑ BCR responses, ↑ serum IgM levels, ↓ T-independent responses, normal T-dependent responses, ↑ B-1 cells, autoantibodies with age | 38, 50–52 |
PKCβ | Viable | Like xid | 21 |
The B cell phenotypes of mice deficient in each candidate gene tested are indicated.